Losartan Potassium
Product Images NDC 68071-2786

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-2786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2786 1)

NuCare Pharmaceuticals, Inc. Losartan Potassium 100mg tablets are a prescription drug used to treat high blood pressure and reduce the risk of stroke in patients with an enlarged heart. The tablets are white to off-white, round in shape, and engraved with "S" on one side and "113" on the other. The tablets are packaged in a bottle containing 120 tablets, with lot number 00000, and an expiration date of 00-00. Patients should keep the drug out of reach of children and store it at a controlled temperature of 68-77°F. In case of any side effects, patients are advised to contact their doctor or call 1-800-FDA-1088.*

FDA Label Image

Chemical Structure (Spl Image1 Structure1)

FDA Label Image

Figure 1 (Spl Image2 Figure1)

The text seems to be a comparison of two drugs, Atenolol and Losartan Potassium, in treating a particular condition. The percentage of patients who achieved the primary endpoint is mentioned along with an adjusted risk reduction percentage and p-value. The numbers 0 to 66 represent study months.*

FDA Label Image

Figure 2 (Spl Image3 Figure2)

This is a clinical study comparison between two medications - Atenolol and Losartan Potassium. The study shows that Losartan Potassium has an adjusted risk reduction rate of 25% with a p-value of 0.001 compared to Atenolol. The chart depicts the percentage of patients with fatal/non-fatal stroke at different study months from 6 to 66.*

FDA Label Image

Figure 3 (Spl Image4 Figure3)

FDA Label Image

Figure 4 (Spl Image5 Figure4)

This is a graph showing the results of a clinical trial comparing Losartan Potassium to Placebo over a 48 month period. The percentage of patients with an event is shown on the y-axis, with values of 60%, 40%, and 20% marked. The x-axis shows the time in months. The trial found a risk reduction of 16.1% with a p-value of 0.022.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.